Gujarat Terce Plans Strategic Exit from Gandhinagar Facility Amid Portfolio Realignment

Image Source : PharmaCompass.com

Gujarat Terce Laboratories Ltd has proposed the sale of its manufacturing unit located in Chhatral, Gandhinagar, Gujarat, as part of a broader asset optimization strategy. The move signals a shift in operational priorities and capital deployment.

Key Highlights:

- The factory, situated at Ravi Estate in Bileshwarpura, spans a WHO-GMP compliant facility specializing in chemical formulations and cephalosporin antibiotics.
- The sale is expected to unlock capital for reinvestment into high-margin therapeutic segments and digital transformation initiatives.

Strategic Context:

- The company aims to consolidate manufacturing operations and focus on newer product lines with higher scalability.
- The decision aligns with Gujarat Terce’s long-term vision to enhance shareholder value through lean manufacturing and asset-light expansion.

Operational Impact:

- No disruption is expected in supply continuity, as production will be absorbed by alternate facilities.
- The company will retain its registered office in Gandhinagar and corporate headquarters in Ahmedabad.

Sources: ZaubaCorp, Gujarat Terce Website, Moneycontrol, Economic Times.